Journal: Virology: Research and Treatment

Increased Detection of Breast Cancer Virus Sequences in Inflammatory Breast Cancer (10/Nov/2009)
Earlier studies have suggested an association between breast cancer aggressiveness and the presence of viral sequences resembling mouse mammary tumor virus (MMTV). This study was to determine if inflammatory breast cancer (IBC) in the United States had a higher proportion of cases with these viral sequences than non-IBC patients and...
Abstract
Full-text PDF
A Review on the Use of Eltrombopag in Patients with Advanced Liver Disease (13/Oct/2009)
Thrombocytopenia is the most common hematological abnormality in patients with chronic, advanced liver disease. In these patients, the presence of severe thrombocytopenia is an obstacle to the performance of invasive diagnostic and therapeutic procedures, and the current standard treatment for these patients is platelet transfusions, a remedy whose characteristics are...
Abstract
Full-text PDF
Pharmacotherapy of Chronic Hepatitis B in Adults: Focus on Tenofovir Disoproxil Fumarate (17/Sep/2009)
Treatment for hepatitis B (HBV), a global disease affecting over 400 million persons, has changed over the past 15 years. Many of the current treatments are oral therapies which suppress HBV viral load and improve liver-related outcomes. However, differences exist in the currently available therapies both in terms of potency...
Abstract
Full-text PDF
Pharmacotherapy of Chronic Hepatitis B with Entecavir (31/Mar/2009)
Emilio PalumboClinic of Paediatric, Hospital of Sondrio, Italy.AbstractActually three nucleotide/nucleoside analogues are used for chronic hepatitis B: lamivudine, adefovir dipivoxil, entecavir and telbivudine. Lamivudine and adefovir are advantageous for oral administration and safety, but they induce a sustained response after withdrawal of therapy in only a minority of patients. Telbivudine...
Abstract
Full-text PDF
A review of the use of telbivudine in the treatment of chronic hepatitis B (30/Mar/2009)
Prista Charuworn and Emmet B. KeeffeDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University Medical Center, Stanford, CA, U.S.A.AbstractChronic hepatitis B is a major global health problem. Fortunately there are currently a number of agents licensed in most countries to treat chronic hepatitis B, including the oral nucleos(t)ide agents...
Abstract
Full-text PDF
Generation of BKV-Specific T Cells for Adoptive Therapy Against BKV Nephropathy (02/Dec/2008)
Jongming Li1, Bijoyesh Mookerjee2, Priya Singh1 and John L Wagner1 1Department of Medical Oncology, 1024 Curtis Building, Thomas Jefferson University, 1015 Walnut St., Philadelphia, PA, U.S.A., 19107. 21800 Concord Pike, AstraZeneca PLC, Wilmington, DE 19850–5437. Abstract Nephropathy associated with BK virus has emerged as an important cause...
Abstract
Full-text PDF
A Case Report of Hepatitis E Infection Leading to Acute Liver Failure and Transplantation (02/Dec/2008)
P. Paskaran1, A.U. Murugananthan2, V. Manglam1, J. Arnold2 and A. Pal1 1Department of Gastroenterology, Ealing Hospital NHS Trust, London. 2Imperial College School of Medicine, London. Abstract Historically, Hepatitis E infection has been thought to follow a benign clinical course. We report a case of Acute Hepatitis E...
Abstract
Full-text PDF
Characterization of Non-Conserved HLA-A*0201 Binding T cell Epitopes of JC Virus T Antigen (09/Sep/2008)
Jongming Li1, John L. Wagner1 and Bijoyesh Mookerjee2 1Department of Medical Oncology, 1024 Curtis Building, Thomas Jefferson University, 1015 Walnut St., Philadelphia, PA 19107. 21800 Concord Pike, AstraZeneca PLC, Wilmington, DE 19850-5437. Abstract JC virus-specific CD8+ cytotoxic T lymphocytes are associated with a favorable outcome in patients...
Abstract
Full-text PDF
Evolution of the G+C Content Frontier in the Rat Cytomegalovirus Genome (09/Sep/2008)
Derek Gatherer MRC Virology Unit, Institute of Virology, University of Glasgow, Church Street, Glasgow, G11 5JR, UK Abstract Within the 230138 bp of the rat cytomegalovirus (RCMV) genome, the G+C content changes abruptly at position 142644, constituting a G+C content frontier. To the left of this...
Abstract
Full-text PDF
Introductory Editorial (Advances in Tumor Virology) (14/Aug/2009)
Frank J. Jenkins Associate Professor, University of Pittsburgh, Pittsburgh, PA
Abstract
Full-text PDF
Successful Management of Multifactorial Colitis in a Recipient of Hematopoietic Stem Cell Transplant: A Case Report (29/Jul/2008)
Khalid A. Al-Anazi1, Asma M. Al-Jasser3, Amal Abdulwahab1, Entezam Sahovic1, Hadeel Almana2 and Mohammed A. Al Fadda2 1Section of Adult Hematology and Hematopoietic Stem Cell Transplant, King Faisal Cancer Centre, King Faisal Specialist Hospital and Research Centre, P.O. Box: 3354, Riyadh 11211, Saudi Arabia. 2Departments of Medicine and Pathology,...
Abstract
Full-text PDF
HIV-1 Transmission, Replication Fitness and Disease Progression (14/Jul/2008)
Tasha Biesinger and Jason T. Kimata Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030. U.S.A. Abstract Upon transmission, human immunodeficiency virus type 1 (HIV-1) establishes infection of the lymphatic reservoir, leading to profound depletion of the memory CD4+T cell population despite the...
Abstract
Full-text PDF
KSHV Latency in Transformed B-cells: The Role of LANA1 as a Therapeutic Target (17/Jun/2008)
Sofia Corte-Real, Lídia Fonseca and Joao Goncalves URIA-Centro de Patogénese Molecular, Faculty of Pharmacy, University of Lisbon, 1649-019 Lisbon, Portugal.
Abstract
Full-text PDF
Functionality of Chimeric E2 Glycoproteins of BVDV and CSFV in Virus Replication (19/Mar/2008)
H.G.P. van Gennip, G.K.W Miedema, R.J.M. Moormann and P.A van Rijn Central Veterinary Institute of (CVI) of Wageningen UR, P.O. Box 2004, 8203 AA Lelystad, The Netherlands. Abstract An intriguing difference between the E2 glycoprotein of CSFV and the other groups of pestiviruses (nonCSFV) is a lack of...
Abstract
Full-text PDF
Identification of Rotavirus VP6-Specific CD4+ T Cell Epitopes in a G1P[8] Human Rotavirus-Infected Rhesus Macaque (03/Mar/2008)
Wei Zhao1, Bapi Pahar1,2 and Karol Sestak1,2 1Tulane National Primate Research Center, Covington, LA, U.S.A. 2Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, U.S.A. Abstract A non-human primate model was used to evaluate its potential for identification of rotavirus viral protein 6 (VP6)...
Abstract
Full-text PDF
An Evidence-Based Approach to Plum Pox Virus Detection by DASI-ELISA and RT-PCR in Dormant Period (10/Feb/2008)
Antonio Olmos, Edson Bertolini, Nieves Capote, Mariano Cambra Centro de Protección Vegetal y Biotecnología, Instituto Valenciano de Investigaciones Agrarias (IVIA), Carretera Moncada a Náquera km 5, 46113 Moncada, Valencia, Spain. Abstract An evidence-based approach, such as those developed in clinical and veterinary medicine, was applied to the detection...
Abstract
Full-text PDF
Oncolytic Viruses: Do They Have a Role in Anti-Cancer Therapy? (09/Feb/2008)
1Robin J Prestwich, 1Fiona Errington, 2,3Kevin J. Harrington, 4Hardev S. Pandha, 1Peter Selby and 1Alan Melcher 1Cancer Research UK, St James’s University Hospital, Beckett Street, Leeds, LS9 7TF, UK. 2Targeted Therapy Laboratory, Institute of Cancer Research, Cancer Research UK. Centre for Cell and Molecular Biology, Chester Beatty Laboratories,...
Abstract
Full-text PDF
Evolution of the Influenza A Virus: Some New Advances (30/Jan/2008)
Raul Rabadan1 and Harlan Robins2 1Institute for Advanced Study, Einstein Dr., Princeton, NJ 08540, U.S.A. 2Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, U.S.A. Abstract Influenza is an RNA virus that causes mild to severe respiratory symptoms in humans and other hosts. Every year approximately half a million...
Abstract
Full-text PDF
Targeting Human Immunodeficiency Virus Type 1 Assembly, Maturation and Budding (17/Sep/2007)
Johanna Wapling1,2, Seema Srivastava1, Miranda Shehu-Xhilaga3,4 and Gilda Tachedjian1,2,3 1Molecular Interactions Group, Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, 3004, Australia. 2Department of Microbiology, Monash University, Clayton, Victoria 3168, Australia. 3Department of Medicine, Monash University, Prahran, Victoria 3181, Australia. 4Infectious Diseases Unit, Alfred Hospital, Prahran, Victoria...
Abstract
Full-text PDF
Lead Optimization in Discovery Drug Metabolism and Pharmacokinetics/Case study: The Hepatitis C Virus (HCV) Protease Inhibitor SCH 503034 (26/Jun/2007)
K.-C. Cheng1, Walter A. Korfmacher1, Ronald E. White1 and F. George Njoroge2 1Department of Drug Metabolism and Pharmacokinetics. 2Chemistry Department Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033 U.S.A.Abstract: Lead optimization using drug metabolism and pharmacokinetics (DMPK) parameters has become one of the primary focuses of research organizations...
Abstract
Full-text PDF
Cyclophilin and Viruses: Cyclophilin as a Cofactor for Viral Infection and Possible Anti-Viral Target (14/Feb/2007)
Koichi Watashi and Kunitada ShimotohnoDepartment of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto, Japan.Abstract: Cyclophilin (CyP) is a peptidyl prolyl cis/trans isomerase, catalyzing the cis-trans isomerization of proline residues in proteins. CyP plays key roles in several different aspects of cellular physiology including the immune response, transcription, mitochondrial...